RCMI Coordinating Center (RCMI CC) Header Logo

Connection

Akira Kawamura to Angiotensin II Type 1 Receptor Blockers

This is a "connection" page, showing publications Akira Kawamura has written about Angiotensin II Type 1 Receptor Blockers.
  1. Morii J, Miura S, Ike A, Shiga Y, Sugihara M, Iwata A, Kawamura A, Nishikawa H, Saku K. Comparison of the efficacies of irbesartan and olmesartan after successful coronary stent implantation. Intern Med. 2013; 52(7):713-9.
    View in: PubMed
    Score: 0.110
  2. Sugihara M, Miura S, Takamiya Y, Kiya Y, Arimura T, Iwata A, Kawamura A, Nishikawa H, Yamagishi S, Saku K. Significance of pigment epithelium-derived factor levels with angiotensin II type 1 receptor blockers in patients with successful coronary stent implantation. J Renin Angiotensin Aldosterone Syst. 2011 Sep; 12(3):320-5.
    View in: PubMed
    Score: 0.095
  3. Sugihara M, Miura S, Takamiya Y, Kiya Y, Arimura T, Iwata A, Kawamura A, Nishikawa H, Uehara Y, Saku K. Safety and efficacy of antihypertensive therapy with add-on angiotensin II type 1 receptor blocker after successful coronary stent implantation. Hypertens Res. 2009 Jul; 32(7):625-30.
    View in: PubMed
    Score: 0.084
  4. Imaizumi S, Miura S, Nishikawa H, Iwata A, Zhang B, Kawamura A, Tsuchiya Y, Kumagai K, Matsuo K, Saku K. Angiotensin II type 1 receptor blockers do not promote coronary collateral circulation in patients with coronary artery disease. Hypertens Res. 2006 Mar; 29(3):135-41.
    View in: PubMed
    Score: 0.067
  5. Iwata A, Miura S, Nishikawa H, Kawamura A, Matsuo Y, Sako H, Kumagai K, Matsuo K, Saku K. Significance of combined angiotensin II receptor blocker and carvedilol therapy in patients with congestive heart failure and arginine variant. J Cardiol. 2006 Jan; 47(1):1-7.
    View in: PubMed
    Score: 0.067
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support